Jefferies Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

Jefferies Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.53M	Buy	45,304 +13,740	+44%	+$458K	0.01%	784
2026 Q1	$951K	Buy	31,564 +16,782	+114%	+$540K	0.01%	946
2025 Q4	$461K	Buy	+14,782	New	+$364K	﹤0.01%	1353
2025 Q1	–	Sell	-15,048	Closed	-$332K	–	1995
2024 Q4	$332K	Buy	+15,048	New	+$274K	﹤0.01%	1232
2024 Q3	–	Sell	-21,250	Closed	-$345K	–	1763
2024 Q2	$345K	Buy	+21,250	New	+$327K	﹤0.01%	1077
2023 Q3	–	Sell	-16,527	Closed	-$124K	–	1987
2023 Q2	$124K	Buy	16,527 +15,523	+1,546%	+$126K	﹤0.01%	1491
2023 Q1	$8.88K	Sell	1,004 -208,470	-100%	-$2.06M	﹤0.01%	1556
2022 Q4	$1.91M	Buy	+209,474	New	+$1.83M	0.01%	672

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Jefferies Financial Group's TEVA Position: Q2 2026 in Review

Jefferies Financial Group increased its Teva Pharmaceuticals (TEVA) stake by 44% in Q2 2026, buying an estimated $458K and bringing the position to 45,304 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #784.

Jefferies Financial Group first reported a position in TEVA in Q4 2022 and has held it in 8 quarters since. The position peaked at $1.91M in Q4 2022. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Jefferies Financial Group held 45,304 shares of Teva Pharmaceuticals worth $1.53M as of Q2 2026.
Jefferies Financial Group bought 13,740 Teva Pharmaceuticals shares in Q2 2026, an estimated $458K.
Teva Pharmaceuticals made up 0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #784 holding.
Jefferies Financial Group first reported a position in Teva Pharmaceuticals in Q4 2022 and has held it in 8 quarters since.
Jefferies Financial Group's Teva Pharmaceuticals position peaked at $1.91M in Q4 2022.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.